• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Veramyst (fluticasone furoate) Nasal Spray

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

 

Summary View

 

CONTRAINDICATIONS

  • Veramyst nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions Including Anaphylaxis
  • Hypersensitivity reactions including anaphylaxis angioedema, rash, and urticaria, may occur after administration of Veramyst Nasal Spray. Discontinue Veramyst nasal spray if such reactions occur

ADVERSE REACTIONS

Postmarketing Experience/Immune System Disorders
  • hypersensitivity reactions including anaphylaxis, angioedema, rash and urticaria